Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2008

01-10-2008 | Article

Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003–2005

Authors: S. C. de Greeff, H. E. de Melker, L. M. Schouls, L. Spanjaard, M. van Deuren

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2008

Login to get access

Abstract

To improve the timeliness of health care delivery to patients with meningococcal disease, the early disease evolution and clinical manifestation at admission were studied in all 752 patients with invasive meningococcal disease in the Netherlands in 2003–2005. Eighty-eight percent (88%) had serogroup B disease. The case fatality rate (CFR) was 6.7% overall, but reached 16% among adults over 50 years of age. The CFR was similar for serogroups B (6.3%) and C (5.2%). Admission followed 17 h (median) after the onset of symptoms. The CFR in patients admitted within 12 h, 12–18 h, 18–36 h or >36 h after the first symptoms was 10.2, 7.8, 3.5 and 2.2%, respectively. Only 60% of patients had skin lesions, and admission followed 2 h (median) later. Earlier recognition can be achieved when non-petechial clues are included in the diagnosis. A short duration of disease before admission is a simple tool in the recognition of patients with severe disease.
Literature
1.
go back to reference van Deuren M, Brandtzaeg P, van der Meer JW (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbial Rev 13:144–166CrossRef van Deuren M, Brandtzaeg P, van der Meer JW (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbial Rev 13:144–166CrossRef
2.
go back to reference Brandtzaeg P, van Deuren M (2005) Meningococcal infections at the start of the 21st century. Adv Pediatr 52:129–162PubMedCrossRef Brandtzaeg P, van Deuren M (2005) Meningococcal infections at the start of the 21st century. Adv Pediatr 52:129–162PubMedCrossRef
3.
go back to reference Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME (2004) Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365–367PubMedCrossRef Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME (2004) Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365–367PubMedCrossRef
4.
go back to reference de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A (2006) Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 25:79–80PubMedCrossRef de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A (2006) Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 25:79–80PubMedCrossRef
5.
go back to reference Larrauri A, Cano R, García M, Mateo S (2005) Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Vaccine 23:4097–4100PubMedCrossRef Larrauri A, Cano R, García M, Mateo S (2005) Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Vaccine 23:4097–4100PubMedCrossRef
6.
go back to reference Mooney JD, Christie P, Robertson C, Clarke SC (2004) The impact of meningococcal serogroup C conjugate vaccine in Scotland. Clin Infect Dis 39:349–356PubMedCrossRef Mooney JD, Christie P, Robertson C, Clarke SC (2004) The impact of meningococcal serogroup C conjugate vaccine in Scotland. Clin Infect Dis 39:349–356PubMedCrossRef
7.
go back to reference Halstensen A, Pedersen SH, Haneberg B, Bjorvatn B, Solberg CO (1987) Case fatality of meningococcal disease in western Norway. Scand J Infect Dis 19:35–42PubMedCrossRef Halstensen A, Pedersen SH, Haneberg B, Bjorvatn B, Solberg CO (1987) Case fatality of meningococcal disease in western Norway. Scand J Infect Dis 19:35–42PubMedCrossRef
8.
go back to reference Smith I, Caugant DA, Høiby EA, Wentzel-Larsen T, Halstensen A (2006) High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985–2002. Epidemiol Infect 134:1195–1202PubMedCrossRef Smith I, Caugant DA, Høiby EA, Wentzel-Larsen T, Halstensen A (2006) High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985–2002. Epidemiol Infect 134:1195–1202PubMedCrossRef
9.
go back to reference Wood AL, O’Brien SJ (1996) How long is too long? Determining the early management of meningococcal disease in Birmingham. Public Health 110:237–239PubMedCrossRef Wood AL, O’Brien SJ (1996) How long is too long? Determining the early management of meningococcal disease in Birmingham. Public Health 110:237–239PubMedCrossRef
10.
go back to reference Trotter C, Samuelsson S, Perrocheau A, de Greeff S, de Melker H, Heuberger S, Ramsay M (2005) Ascertainment of meningococcal disease in Europe. Euro Surveill 10:247–250PubMed Trotter C, Samuelsson S, Perrocheau A, de Greeff S, de Melker H, Heuberger S, Ramsay M (2005) Ascertainment of meningococcal disease in Europe. Euro Surveill 10:247–250PubMed
11.
go back to reference de Greeff SC, Spanjaard L, Dankert J, Hoebe CJ, Nagelkerke N, de Melker HE (2006) Underreporting of meningococcal disease incidence in the Netherlands: results from a capture–recapture analysis based on three registration sources with correction for false positive diagnoses. Eur J Epidemiol 21:315–321PubMedCrossRef de Greeff SC, Spanjaard L, Dankert J, Hoebe CJ, Nagelkerke N, de Melker HE (2006) Underreporting of meningococcal disease incidence in the Netherlands: results from a capture–recapture analysis based on three registration sources with correction for false positive diagnoses. Eur J Epidemiol 21:315–321PubMedCrossRef
12.
go back to reference Rothman KJ (2002) Epidemiology: an introduction. Oxford University Press, New York Rothman KJ (2002) Epidemiology: an introduction. Oxford University Press, New York
13.
go back to reference Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM) (2006) Bacterial meningitis in the Netherlands; annual report 2005. University of Amsterdam, Amsterdam Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM) (2006) Bacterial meningitis in the Netherlands; annual report 2005. University of Amsterdam, Amsterdam
14.
go back to reference Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J (1997) Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rev 7:R49–R54 Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J (1997) Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rev 7:R49–R54
15.
go back to reference Paret G, Keller N, Barzilai A, Zemach M, Guttman D, Vardi A, Shatzberg G, Cohen H, Barzilay Z (1999) Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control. Infection 27:261–264PubMedCrossRef Paret G, Keller N, Barzilai A, Zemach M, Guttman D, Vardi A, Shatzberg G, Cohen H, Barzilay Z (1999) Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control. Infection 27:261–264PubMedCrossRef
16.
go back to reference Shigematsu M, Davison KL, Charlett A, Crowcroft NS (2002) National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999–June 2001. Epidemiol Infect 129:459–470PubMedCrossRef Shigematsu M, Davison KL, Charlett A, Crowcroft NS (2002) National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999–June 2001. Epidemiol Infect 129:459–470PubMedCrossRef
17.
go back to reference Smith I, Bjørnevik AT, Augland IM, Berstad A, Wentzel-Larsen T, Halstensen A (2006) Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985–2002. Epidemiol Infect 134:103–110PubMedCrossRef Smith I, Bjørnevik AT, Augland IM, Berstad A, Wentzel-Larsen T, Halstensen A (2006) Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985–2002. Epidemiol Infect 134:103–110PubMedCrossRef
18.
go back to reference Bøvre K, Frøholm LO, Gaustad P, Holten E, Høiby EA (1983) Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981–1982. NIPH Ann 6:75–84PubMed Bøvre K, Frøholm LO, Gaustad P, Holten E, Høiby EA (1983) Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981–1982. NIPH Ann 6:75–84PubMed
19.
go back to reference Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355–357PubMedCrossRef Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355–357PubMedCrossRef
20.
go back to reference Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sørensen E (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195–204PubMed Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sørensen E (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195–204PubMed
21.
go back to reference van Deuren M, Neeleman C, Van’t Hek LG, van der Meer JW (1998) A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course. Intensive Care Med 24:157–161PubMedCrossRef van Deuren M, Neeleman C, Van’t Hek LG, van der Meer JW (1998) A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course. Intensive Care Med 24:157–161PubMedCrossRef
22.
go back to reference Stiehm ER, Damrosch DS (1966) Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr 68:457–467PubMedCrossRef Stiehm ER, Damrosch DS (1966) Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr 68:457–467PubMedCrossRef
23.
24.
go back to reference Riordan FA, Marzouk O, Thomson AP, Sills JA, Hart CA (2002) Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods. Eur J Pediatr 161:531–537PubMedCrossRef Riordan FA, Marzouk O, Thomson AP, Sills JA, Hart CA (2002) Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods. Eur J Pediatr 161:531–537PubMedCrossRef
25.
go back to reference Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M (2006) Clinical recognition of meningococcal disease in children and adolescents. Lancet 367:397–403PubMedCrossRef Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M (2006) Clinical recognition of meningococcal disease in children and adolescents. Lancet 367:397–403PubMedCrossRef
26.
go back to reference Tønjum T, Nilsson F, Bruun JN, Haneberg B (1983) The early phase of meningococcal disease. NIPH Ann 6:175–181PubMed Tønjum T, Nilsson F, Bruun JN, Haneberg B (1983) The early phase of meningococcal disease. NIPH Ann 6:175–181PubMed
27.
go back to reference Louria DB, Sen P, Kapila R, Johnson E, Smith L, Roberts R (1985) Anterior thigh pain or tenderness. A diagnostically useful manifestation of bacteremia. Arch Intern Med 145:657–658PubMedCrossRef Louria DB, Sen P, Kapila R, Johnson E, Smith L, Roberts R (1985) Anterior thigh pain or tenderness. A diagnostically useful manifestation of bacteremia. Arch Intern Med 145:657–658PubMedCrossRef
28.
go back to reference Inkelis SH, O’Leary D, Wang VJ, Malley R, Nicholson MK, Kuppermann N (2002) Extremity pain and refusal to walk in children with invasive meningococcal disease. Pediatrics 110:e3PubMedCrossRef Inkelis SH, O’Leary D, Wang VJ, Malley R, Nicholson MK, Kuppermann N (2002) Extremity pain and refusal to walk in children with invasive meningococcal disease. Pediatrics 110:e3PubMedCrossRef
29.
go back to reference Granier S, Owen P, Pill R, Jacobson L (1998) Recognising meningococcal disease in primary care: qualitative study of how general practitioners process clinical and contextual information. BMJ 316:276–279PubMed Granier S, Owen P, Pill R, Jacobson L (1998) Recognising meningococcal disease in primary care: qualitative study of how general practitioners process clinical and contextual information. BMJ 316:276–279PubMed
31.
go back to reference Hackett SJ, Guiver M, Marsh J, Sills JA, Thomson AP, Kaczmarski EB, Hart CA (2002) Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 86:44–46PubMedCrossRef Hackett SJ, Guiver M, Marsh J, Sills JA, Thomson AP, Kaczmarski EB, Hart CA (2002) Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 86:44–46PubMedCrossRef
32.
go back to reference Øvstebø R, Brandtzaeg P, Brusletto B, Haug KB, Lande K, Høiby EA, Kierulf P (2004) Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 42:2980–2987PubMedCrossRef Øvstebø R, Brandtzaeg P, Brusletto B, Haug KB, Lande K, Høiby EA, Kierulf P (2004) Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 42:2980–2987PubMedCrossRef
Metadata
Title
Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003–2005
Authors
S. C. de Greeff
H. E. de Melker
L. M. Schouls
L. Spanjaard
M. van Deuren
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0535-1

Other articles of this Issue 10/2008

European Journal of Clinical Microbiology & Infectious Diseases 10/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine